Igs present in the sera of normal individuals in the absence of exogenous antigenic stimulation are termed natural antibodies (NAbs). The repertoire and reactivity pattern of NAbs are conserved both within and between species ([@bib2]) and are remarkably stable. IgM is the dominant NAb isotype, and most, if not all, NAbs appear to be the products of B-1 B cells ([@bib29], [@bib30]; [@bib66]; [@bib26]; [@bib4]; [@bib12]). The Igs produced by these lymphocytes often demonstrate decreased or absent N-region addition at the V-D and D-J junctions, emphasizing the major contribution of germline-encoded sequence to their specificity ([@bib21]; [@bib71]; [@bib38]; [@bib72]). NAbs are considered to constitute an innate component of the adaptive immune response, as they provide one of the first lines of defense against invading pathogens ([@bib9]; [@bib5]; [@bib55]).

In mice, NAbs are present at equivalent levels in specific pathogen--, germ-, and even exogenous antigen--free animals, suggesting a role for endogenous ligands in the selection of the NAb repertoire ([@bib8]; [@bib28]). Accordingly, elegant experiments have shown that naturally generated B-1 B cells secreting antithymocyte NAb required the presence of the cognate endogenous antigen (Thy-1/CD90) for B cell expansion and serum autoantibody secretion ([@bib32]). Some NAbs also appear to play a role in normal cellular homeostasis, helping rid the body of cellular and molecular debris ([@bib1]; [@bib6]; [@bib39]). One classical example in mice of the dual role of NAbs involves the NAb response to endogenous oxidation-specific epitopes on oxidized low-density lipoprotein (LDL \[OxLDL\]) and apoptotic cells ([@bib64]; [@bib7]; [@bib6]; [@bib11]; [@bib13]). In response to OxLDL, there appears to be selection and expansion of NAbs bearing the germline-encoded T15 idiotype (T15-Id) in the peripheral B cell repertoire ([@bib64]; [@bib40]). T15-Id^+^ NAbs also bind to phosphorylcholine (PC) present on the cell wall of *Streptococcus pneumoniae* ([@bib56]; [@bib9]), constituting 60--80% of the natural anti-PC response ([@bib25]; [@bib67]; [@bib44]; [@bib24]). Although many antibodies can bind PC, those containing the germline canonical T15-Id confer optimal protection against lethal *S. pneumoniae* bacteremia ([@bib47]) and fatal sepsis ([@bib10]) in mice, and low levels of IgM antibodies to PC have been recently associated with a higher risk of cardiovascular disease in humans ([@bib18]).

Although the key roles played by NAbs in host homeostasis and defense are increasingly appreciated, a major remaining question is the nature of the forces that shape the composition of the NAb repertoire. One thesis, which we may refer to as the natural selection hypothesis, holds that the germline composition of the NAb repertoire is critical for its dual function as a protector against both endogenous and exogenous antigens and thus has been naturally selected during evolution. The antithesis, which we may refer to as the self-antigen--driven or somatic selection hypothesis, proposes that exposure to self-antigen drives the production of dual-function NAbs irrespective of germline sequence.

The T15-Id is conserved across multiple mouse strains and is tightly associated with the use of a specific V~H~ (*V~H~S107.1*) and a specific V~L~ (*V~κ~22*; [@bib17]). Disruption of the *V~H~S107.1* gene results in an inability to mount a protective immune response to *S. pneumoniae* ([@bib48]). In common with many other B-1a Igs, canonical anti-PC T15 CDR-H3s lack N-region addition and use their D~H~, in this case *DFL16.1*, in only one of six potential reading frames, RF1 ([@bib21]). These findings raised the possibility that the complete germline sequence of DFL16.1 in general, and of RF1 in particular, would be critical for NAb protection against *S. pneumoniae*, with N addition playing a deleterious role ([@bib5]). However, this presumed centrality of naturally selected *DFL16.1* germline sequence, either partial or in its entirety, in promoting production of NAb induced by endogenous OxLDL and in preventing potentially atherogenic uptake of this lipid has not been experimentally verified.

In this work, we report the use of a panel of BALB/c mice with altered D~H~ alleles ([@bib60], [@bib62]; [@bib35]; [@bib76]) to both qualitatively and quantitatively test the relative roles of germline versus somatic selection of CDR-H3 sequence in the generation and function of the anti-OxLDL, anti-PC, and T15-Id^+^ NAb repertoires. We present data that support the moderating concept that natural selection of conserved D (diversity) sequence and self-antigen--driven somatic selection operate in concert to create a protective, functional NAb repertoire reactive with a bacterial cell wall component. In remarkable contrast, NAb reactivity and function in the case of an endogenous antigen representative of molecular debris do not show this dependence on evolutionarily conserved D~H~ sequences.

RESULTS
=======

Evidence for a conserved range of self-reactivities expressed by the NAb repertoire despite changes in its germline composition
-------------------------------------------------------------------------------------------------------------------------------

We had previously used techniques of cre-loxP--based gene targeting on a BALB/c embryonic stem cell line to delete 12 of the 13 D~H~ gene segments in the D~H~ locus, retaining only the single *DFL16.1* segment (*ΔD-DFL* mice). We then generated a panel of D~H~-altered mice by replacing the single *DFL16.1* segment with a twice-frameshifted *DFL16.1* gene segment (*ΔD-DµFS*) or an inverted *DSP2.2* gene segment (*ΔD-iD*; [@bib60], [@bib62]; [@bib35]; [@bib76]; [@bib63]).

To gain insight into the role played by germline D~H~ sequence in the antigen specificity of the NAb repertoire, we performed a semiquantitative immunoblot assay that enables an en bloc analysis of the self-reactivity of IgM present in the serum of unmanipulated WT and the D~H~-altered mutant mice ([@bib54]; [@bib27]; [@bib51]). Sera were tested for reactivity to self-proteins isolated from brain, muscle, heart, and liver ([Fig. S1 A](http://www.jem.org/cgi/content/full/jem.20121861/DC1){#supp1} and not depicted). The serum IgM self-reactivity pattern (actual repertoire) was remarkably well-conserved in mice that generate very different primary CDR-H3 repertoires at multiple stages and subsets of B cell development, including the B-1 compartments (unpublished data). To test whether the self-reactivity pattern observed in serum is also conserved at the cellular level (available repertoire), we sorted and cultured peritoneal cavity (PerC) B-1a, B-1b, and B-2 cells under mitogen stimulation to induce polyclonal IgM secretion and tested the supernatants using the immunoblot assay. Whereas the self-reactivity profiles from B-1a culture supernatants were highly conserved among the different mouse strains, reflecting those observed in the serum, there was less conservation in B-1b and still less in the B-2 cell culture supernatants (Fig. S1 B). These results suggest that the self-reactivity profile of the serum NAb repertoire is conserved and is essentially independent of germline D~H~ sequence.

Serum levels and potential physiological function of anti-OxLDL NAbs are maintained despite limitation and alterations of D~H~ genes
------------------------------------------------------------------------------------------------------------------------------------

The remarkable conservation of NAb self-reactivities observed in the en bloc immunoblot assay could also suggest conservation of function. To test both the reactivity and function of the NAb produced by these gene-altered mice, we turned to the well-defined T15 system. Essentially two CDR-H3 T15 prototypes are generated by the IgH allele of BALB/c WT mice, the dominant one entirely encoded by the germline V~H~, J~H~, and D~H~ *DFL16.1* RF1 gene segment sequence ([Fig. 1 A](#fig1){ref-type="fig"}, top; [@bib21]). Our panel of mice provided us with a suitable range of alternative D~H~ sequences to study the relationship between naturally selected, germline D~H~ amino acid sequence, both for self-reactivity and for protection against a common exogenous pathogen (for further details see [Fig. 1 A](#fig1){ref-type="fig"} and Materials and methods).

![**The serum levels and potential functionality of anti-OxLDL IgM NAbs are unaffected by changes in the germline sequence of the D~H~ locus.** (A) Schematic representation of the BALB/c WT D~H~ and D~H~-altered loci in the context of T15 prototypic sequences. (top) Amino acid sequence of the prototypic T15 CDR-H3 ([@bib21]) compared with the germline sequences of *V~H~S107.1*, *D~H~DFL16.1*, and *J~H~1*; "-" indicates identical amino acid usage, and "X" indicates alternative amino acid usage. Amino acid sequences were encoded by each D~H~-altered allele in the three direct RFs: *ΔD-DFL* (upper middle), *ΔD-DµFS* (lower middle), and *ΔD-iD* allele (bottom). Neutral, hydrophobic, and charged amino acids are shown in green, blue, and red, respectively; asterisks indicate termination codons. (B) Levels of serum anti-OxLDL IgM in WT and D~H~-altered naive mice. (left) Levels of IgM antibodies are shown as an equivalent titer (µg/ml) to the BALB/c IgM anti-PC--producing hybridoma BH8 ([@bib41]). The horizontal lines indicate the mean value of each group. (right) Anti-OxLDL IgM levels expressed as ratios between anti-OxLDL and anti--Nat-LDL in absorbance units. (C) Immunoenzymatic analysis of inhibition of Biot-OxLDL binding to RAW 264.7 macrophages. RAW 264.7 macrophages were incubated with Biot-OxLDL in the presence of 1:5, 1:10, and 1:20 diluted pooled sera from each mouse strain. The extent of OxLDL binding is expressed as optical density. (B and C) Error bars indicate SD of the mean. (D) Representative flow cytometric analysis of inhibition of Biot-OxLDL binding to RAW 264.7 macrophages. Cells were incubated in the absence (dark line) or presence of Biot-OxLDL. RAW 264.7 macrophages were incubated with Biot-OxLDL in the presence of 1:5, 1:10 (shown), and 1:20 diluted pooled sera from each mouse strain. The extent of OxLDL binding is expressed as the intensity of PE fluorescence. (E) Representative confocal microscopy images of inhibition of DiI-OxLDL binding/uptake to RAW 264.7 macrophages. RAW 264.7 macrophages were incubated with DiI-OxLDL in the presence of 1:5 (shown), 1:10, and 1:20 (shown) diluted pooled sera from each mouse strain. The extent of OxLDL binding/uptake was examined with a 63× oil immersion objective using a 546-nm filter set. In each assay, the specific binding of Biot-OxLDL or DiI-OxLDL to the macrophages was shown by incubation in the absence (No comp.) and presence of 50-fold excess of unconjugated OxLDL or Nat-LDL. Each assay was performed in at least two independent experiments, and one representative dataset is shown. Bars, 30 µm.](JEM_20121861_Fig1){#fig1}

In unmanipulated mice, we found that consistent with our en bloc analysis, the physiological levels of anti-OxLDL NAbs were indistinguishable among the different strains, irrespective of the availability of evolutionarily conserved *DFL16.1* gene segment sequence ([Fig. 1 B](#fig1){ref-type="fig"}). To test the antiatherogenic potential of anti-OxLDL NAbs generated under varying levels of *DFL16.1* availability, we then used immunoenzymatic ([Fig. 1 C](#fig1){ref-type="fig"}), flow cytometry ([Fig. 1 D](#fig1){ref-type="fig"}), and confocal microscopy ([Fig. 1 E](#fig1){ref-type="fig"}) assays to evaluate the capacity of sera from each mouse strain to inhibit binding/uptake of OxLDL to macrophages. In each case, we found that pooled serum from each D~H~-altered mouse strain was equally efficacious to WT in blocking binding of OxLDL to macrophages. Collectively, these results suggested that both anti-OxLDL NAb serum levels and functionality had apparently been both qualitatively and quantitatively unaffected by the enhancement, alteration, or complete elimination of germline *DFL16.1* gene segment sequence usage.

Loss of the DFL16.1 gene sequence decreases the physiological levels of serum anti-PC antibodies
------------------------------------------------------------------------------------------------

We then tested whether the production of anti-PC NAbs had been influenced by altering D~H~. We first measured the levels of anti-PC antibodies in the serum of naive mice ([Fig. 2 A](#fig2){ref-type="fig"}). To perform quantitative calculations for this analysis, we used a parameter that we term *R* value ([Table 1](#tbl1){ref-type="table"}; for further details see Materials and methods), which is an expression of the likelihood of the use of the *DFL16.1* RF1 sequence. We related the *R* value to the prevalence of anti-PC antibodies bearing the T15-Id. Among the seven homozygous and heterozygous genotypes of mice examined ([Table 1](#tbl1){ref-type="table"}), the titer of anti-PC NAbs was lowest in the complete absence of *DFL16.1* (homozygous *ΔD-iD* mice, P \< 0.001 and P \< 0.001 versus both WT and *ΔD-DFL*, respectively), followed by the heterozygous WT/*ΔD-iD* ([Fig. 2 A](#fig2){ref-type="fig"}). Anti-PC production in both heterozygous and homozygous *ΔD-DµFS* mice, which retained the *DFL16.1* core sequence, was lower than WT but not significantly so. However, anti-PC production proved highest in the heterozygous *ΔD-DFL*/WT mice, followed by the homozygous *ΔD-DFL* mice (P \< 0.001 and P \< 0.01, respectively, when compared with WT). Evaluation of the anti-PC titer as a potential function of the use of *DFL16.1* in RF1 relative to the WT (*R* value) revealed a strong, positive correlation (r = 0.82; P = 0.02; [Fig. 2 A](#fig2){ref-type="fig"}, inset). Competition assays showed that the binding of serum IgM from each of the mouse strains to PC-BSA was significantly inhibited by PC-KLH (at least 60%), indicating that most of the natural IgM bound specifically to PC and not to the carrier link ([Fig. 2 B](#fig2){ref-type="fig"}). These data suggested that, contrary to what was observed for anti-OxLDL NAbs, the availability of B cells incorporating germline-encoded *DFL16.1* RF1 sequence into their Ig H chains might directly influence the physiological production of anti-PC NAbs.

![**Loss of evolutionary conserved D~H~ sequence quantitatively decreases the serum levels of anti-PC NAbs but not the frequency of anti-PC B-1a precursors.** (A) Levels of serum natural anti-PC IgM in WT and D~H~-altered naive mice as a function of the relative use of *DFL16.1* in RF1 (*R* value). The data are combined from three independent experiments. The *R* value was calculated as shown in [Table 1](#tbl1){ref-type="table"} and detailed in Materials and methods. The horizontal lines indicate the mean value of each group. Significantly different from WT: \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001. Significantly different from *ΔD-DFL*: ^\#\#^, P ≤ 0.01; ^\#\#\#^, P ≤ 0.001. (inset plot) Mean serum concentrations (±SD) of anti-PC from each mouse strain are presented as a function of *R* value. A regression line is plotted. The strength of the relationship between antibody production and *R* value was calculated and is given in each panel as *r*, Pearson's correlation coefficient, and the p-value of the analysis. Levels of IgM antibodies are shown as an equivalent titer (µg/ml) to the BALB/c IgM anti-PC--producing hybridoma BH8 ([@bib41]). (B) A constant amount of pooled sera from WT and D~H~-altered naive mice was incubated with PC-BSA in the absence or presence of increasing amounts of PC-KLH. At least five sera samples were included in each pool. Data are the mean of triplicate determinations expressed as ratio of IgM binding to PC-BSA in the presence (B) or absence (B~0~) of competitor (B/B~0~). (C) Frequency of PerC B-1a cells bearing IgM anti-PC estimated by flow cytometry. Histogram bars show the mean percentage of B-1a IgM^+^ PC-DEX^+^ from each mouse strain. At least four mice per group were used for each independent experiment. Error bars indicate SD of the mean. (D) PerC B-1a cells were sorted, and variable numbers of cells were cultured under polyclonal stimulation for IgM secretion. The frequency of B-1a cells secreting IgM anti-PC in vitro was estimated by LDA. Histogram bars show the frequency, calculated by the Poisson distribution, of culture supernatants containing anti-PC IgM. Experiments displayed in B--D were performed at least twice.](JEM_20121861_Fig2){#fig2}

###### 

Calculation of the use of DFL16.1 in RF1 relative to the WT mice

  Genotype (alleles A/B)                                 Allele A   Allele B   *R* value                     
  ------------------------------------------------------ ---------- ---------- ----------- ------ --- ------ ------
  *ΔD-DFL*/*ΔD-DFL*[a](#tblfn1){ref-type="table-fn"}     1          5          1           1      5   1      5
  *ΔD-DFL*/WT                                            1          5          1           1      1   1      3
  WT/WT                                                  1          1          1           1      1   1      1
  *ΔD-DµFS*/WT                                           0.59       5          0.33        1      1   1      0.99
  Δ*D-DµFS*/Δ*D-DµFS*[b](#tblfn2){ref-type="table-fn"}   0.59       5          0.33        0.59   5   0.33   0.97
  Δ*D-iD*/WT                                             0.48       0          1           1      1   1      0.5
  Δ*D-iD*/Δ*D-iD*[c](#tblfn3){ref-type="table-fn"}       0.48       0          1           0.48   0   1      0

R1 is the proportion of mature recirculating IgM^+^ IgD^+^ B cells in the bone marrow relative to WT. R2 is the expected frequency of *DFL16.1* gene usage relative to WT. R3 is the expected frequency of RF1 usage relative to WT. The formula used to calculate the *R* value is \[*R*~allele\ A~ (R1 × R2 × R3) + *R*~allele\ B~ (R1 × R2 × R3)\] × 0.5.

The data used to calculate the R1, R2, and R3 values were retrieved from [@bib60].

The data used to calculate the R1, R2, and R3 values were retrieved from [@bib62] and [@bib76].

The data used to calculate the R1, R2, and R3 values were retrieved from [@bib35].

Frequency of potential anti-PC precursors is not obviously altered by availability of the germline *DFL16.1* gene segment
-------------------------------------------------------------------------------------------------------------------------

We next tested whether these serum NAb alterations reflected differences in the frequency of anti-PC B cell clones, focusing on the PerC B-1a population. We observed that the germline composition of the D~H~ locus had little, if any, effect in determining the frequency of B-1a cells in the PerC-bearing BCRs with anti-PC reactivity ([Fig. 2 C](#fig2){ref-type="fig"}), as analyzed by flow cytometry. To further confirm our finding that PC-specific B cell frequencies were unaffected by *DFL16.1* sequence alteration or loss, we tested the capacity of individual B cells to secrete anti-PC antibody in vitro. Limiting dilution analysis (LDA) showed no significant correlation between *R* and the frequency of B-1a clones secreting anti-PC IgM, confirming the results of flow cytometric analysis ([Fig. 2 D](#fig2){ref-type="fig"}). Thus, in contrast to the D~H~ sequence--associated variation in the serum levels of the anti-PC NAbs (actual anti-PC repertoire), the prevalence of PerC B-1a cells with the potential to secrete anti-PC antibodies (available anti-PC repertoire) did not appear to be affected by changes in or loss of *DFL16.1* germline sequence content.

Availability of germline *DFL16.1* gene sequence quantitatively controls both the serum levels and the frequency of B-1a cells producing anti-PC T15-Id^+^ antibodies
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

In BALB/c WT mice, 60--80% of anti-PC antibodies have been reported to be T15-Id^+^ ([@bib68]; [@bib24]). We thus postulated that the decrease in the serum levels of anti-PC NAbs observed in mice either lacking *DFL16.1* entirely or possessing an altered *DFL16.1* sequence would be accompanied by a decrease in serum T15-Id^+^ NAb levels. Using the T15 clone--specific antibody (AB1.2), we found that the titer of T15-Id^+^ antibodies in the homozygous *ΔD-iD* mice was at least one log lower than that of the other six genotypes (P \< 0.05 for both the WT and *ΔD-DFL* mice; [Fig. 3 A](#fig3){ref-type="fig"}). When compared with homozygous *ΔD-DFL* mice, T15-Id^+^ antibodies were also less common in both heterozygous WT/*ΔD-iD* mice (P \< 0.05) and homozygous *ΔD-DμFS* mice (P \< 0.05). As observed in the total anti-PC serum levels, there was a strong positive correlation between T15-Id^+^ levels and the *R* value (r = 0.80; P = 0.03; [Fig. 3 A](#fig3){ref-type="fig"}, inset). To independently estimate the levels of antibodies that express V~H~-T15 (*V~H~S107.1*) and V~L~-T15 (*V~κ~22*), we used two additional antibodies, designated TC68 and TC139, respectively. Although the serum levels of antibodies using the *V~H~S107.1* heavy chain gene were significantly lower in the mice using the *ΔD-iD* allele when compared with WT or mice using the *ΔD-DFL* allele, we did not observe a positive correlation with *R* ([Fig. 3 B](#fig3){ref-type="fig"}). In contrast, the prevalence of *V~κ~22* light chain--containing serum antibodies in the seven genotypes roughly followed the same pattern observed in anti-PC antibody reactivity ([Fig. 3 C](#fig3){ref-type="fig"}), with a high degree of correlation between *V~κ~22* prevalence and *R* (r = 0.78; P \< 0.04; [Fig. 3 C](#fig3){ref-type="fig"}, inset). A competition assay using AB1.2 as a competitor showed 55%, 70%, and 80% inhibition of IgM binding to PC-BSA in *ΔD-DµFS*, WT, and *ΔD-DFL* homozygous mice, respectively. No significant inhibition was observed in pooled *ΔD-iD* sera, suggesting that the low level of T15-Id^+^ reactivity in these mice reflected binding to noncanonical T15-V~H~-- and/or T15-V~L~--containing antibodies, perhaps caused by weakly cross-reactive determinants ([Fig. 3 D](#fig3){ref-type="fig"}). These data suggest that the availability of germline-encoded *DFL16.1* gene segment sequence quantitatively determines the physiological production of anti-PC antibodies through the control of T15-Id^+^ expression.

![**Loss of *DFL16.1* RF1 sequence quantitatively controls both the serum levels of T15-Id^+^ NAbs and the frequency of anti-PC T15-Id^+^ B-1a cells.** (A--C) Levels of serum IgM expressing the T15-Id^+^ (A), IgM antibodies dependent on the use of the heavy chain *V~H~S107.1* gene segments, TC68^+^ (B), and IgM antibodies dependent on the use of the light chain *V~κ~22* gene segments, TC139^+^ (C), in WT and D~H~-altered naive mice as a function of the relative use of *DFL16.1* in RF1 (*R* value). The data are combined from three independent experiments. The horizontal lines indicate the mean value of each group. (inset plots) Mean serum concentrations (±SD) of IgM T15-Id^+^, TC68^+^, or TC139^+^ from each mouse strain are presented as a function of *R* value. Significantly different from WT: \*, P ≤ 0.05; \*\*\*, P ≤ 0.001. Significantly different from *ΔD-DFL*: ^\#^, P ≤ 0.05; ^\#\#^, P ≤ 0.01; ^\#\#\#^, P ≤ 0.001. Levels of IgM antibodies are shown as an equivalent titer (µg/ml) to the BALB/c IgM anti-PC--producing hybridoma BH8 ([@bib41]). (D) A constant amount of pooled sera from WT and D~H~-altered naive mice was incubated with PC-BSA in the absence or presence of increasing amounts of monoclonal AB1.2 anti--T15-Id antibody. At least five sera samples were included in each pool. Data are the mean of triplicate determinations expressed as the ratio of IgM binding to PC-BSA in the presence (B) or absence (B~0~) of competitor (B/B~0~). (E) Frequency of PerC B-1a cells bearing IgM anti-PC T15-Id^+^ estimated by flow cytometry. Histogram bars show the mean percentage of B-1a PC-DEX^+^ AB1.2^+^ from WT and D~H~-altered naive mice. At least four mice per group were used for each independent experiment. Error bars indicate SD of the mean. (F) Frequency of sorted peritoneal B-1a cells secreting IgM T15-Id^+^ in vitro, as estimated by LDA. Histogram bars show the frequency of culture supernatants containing AB1.2^+^ IgM from each mouse strain. Experiments displayed in D--F were performed at least twice.](JEM_20121861_Fig3){#fig3}

By FACS and LDA, we then analyzed the frequency of B-1a cells in the PerC bearing anti-PC T15-Id^+^ IgM. Contrary to the relatively stable numbers of B-1a cells bearing anti-PC BCRs, the frequency of T15-Id^+^ B-1a cells directly correlated with the *R* value, thus reflecting the availability of germline *DFL16.1* gene segment sequence in RF1 ([Fig. 3, E and F](#fig3){ref-type="fig"}). These data support the view that the potential to secrete T15-Id^+^ antibodies is also qualitatively dependent on the germline sequence of the D~H~ locus.

The frequency of transcripts encoding the classical T15 CDR-H3 amino acid sequence in the anti-PC B-1a precursors is directly proportional to the availability of the *DFL16.1* RF1 sequence
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

We next examined at the amino acid level the actual composition of the PC-specific Ig heavy chain repertoire in B-1a cells from mice with varying access to *DFL16.1* RF1 sequence. From the PerC of homozygous D~H~-altered and WT mice, we sorted PC-DEX^+^ AB1.2^+^ B-1a cells and sequenced their CDR-H3 ([Fig. 4 A](#fig4){ref-type="fig"}). The classical T15 CDR-H3 amino acid sequence was found only in the B-1a cell population that stained highly for PC-DEX and AB1.2 ([Fig. 4 A](#fig4){ref-type="fig"} and [Table S1](http://www.jem.org/cgi/content/full/jem.20121861/DC1){#supp2}). This is consistent with observations by Dizon and Kearney, showing by flow cytometry that only the PC-DEX^hi^ B cell population is inhibitable using PC-BSA as a blocking reagent (unpublished data). Indeed, we found that the T15 heavy chain prototype was found only in B-1a cells derived from mice that carry the *DFL16.1* gene segment sequence in proportions dependent on its availability for usage, i.e., 70%, 25%, and ∼4% in *ΔD-DFL*, WT, and *ΔD-DµFS* mice, respectively ([Fig. 4 B](#fig4){ref-type="fig"}). Strikingly, both the prevalence of N addition and the diversity of V~H~/J~H~ usage increased as the complete sequence of *DFL16.1* in RF1 became less available to the D~H~-altered mice ([Fig. 4 B](#fig4){ref-type="fig"} and Table S1).

![**Junctional diversity rescues the T15-Id in mice forced to use the frameshifted *DFL16.1* gene segment.** (A) Flow cytometry plots show representative gates used to sort peritoneal B-1a cells that stain highly for PC-DEX and AB1.2 from each mouse strain. Peritoneal B-1a cells were sorted from at least five mice per group to achieve sufficient numbers of cells for RNA extraction and sequencing. (B) CDR-H3 analysis of transcripts of sorted PC-DEX^hi^ AB1.2^+^ B-1a cells from each mouse strain. V~H~ usage, pie charts depict the proportion of V~H~ gene usage. N-region, pie charts depict the proportion of N-region addition distributed by the number of N nucleotides added at both junctions. The numbers represent the amount of N nucleotides added at both junctions. J~H~ usage, pie charts depict the proportion of J~H~ element usage. The numbers represent the J~H~ gene segment. Clonal diversity, pie charts depict the proportion of individual sequences, and the prototypic T15 is in gray (see [Fig. 1 A](#fig1){ref-type="fig"} and [Table S1](http://www.jem.org/cgi/content/full/jem.20121861/DC1){#supp3}). (C) CDR-H3 nucleotide and amino acid sequences found in the T15 prototypes in each mouse strain. The V-D and D-J overlap sequences are represented in bold, the *DFL16.1* canonical sequences in green, and N-region addition in blue. (D) Shown are the S107-1 primer sequence homologies with *V~H~S107* family and with members of the *V~H~7183* family ([@bib20]). A red letter indicates a mismatch between the S107-1 primer and the V~H~7183 consensus sequence.](JEM_20121861_Fig4){#fig4}

N addition can be used to recreate the canonical T15 CDR-H3 amino acid sequence if partial *DFL16.1* RF1 sequence is available
------------------------------------------------------------------------------------------------------------------------------

Detailed analysis of the CDR-H3 sequence in transcripts from B-1a cells revealed that junctional diversity, including N-region addition and nucleotide nibbling, can rescue the canonical V~H~-T15 sequences in mice forced to use the frameshifted *DFL16.1* gene segment (*ΔD-DµFS*), which preferentially encodes hydrophobic sequences in place of the neutral T15 amino acid sequence. Extensive nucleotide nibbling at the 3′ end of the D~H~ segment eliminated the D/J microhomology that otherwise would have helped guide D→J rearrangement into the frameshifted RF2 as well as the stop codon near the 3′ terminus of RF1 created by the *DµFS* frameshift ([Fig. 4 C](#fig4){ref-type="fig"}). N addition at both the V-D and D-J junctions then created a complete, canonical CDR-H3 T15 amino acid sequence. Although in this case the data suggest that somatic selection, perhaps driven by endogenous antigen, can rescue and expand rare TdT-dependent T15 B cell clones, the low frequency observed suggests that the power of N addition to create the T15-Id is limited and dependent on the availability of at least partial *DFL16.1* germline RF1 sequence because we were unable to detect the presence of such N nucleotide--generated T15 B cell clones in the *ΔD-iD* mice.

Loss of the evolutionary conserved D~H~ sequence severs the link between anti-PC and anti-OxLDL reactivities
------------------------------------------------------------------------------------------------------------

To gain insight into the quality of serum anti-PC antibodies from mice with varying access to *DFL16.1* RF1 sequence, we determined the levels of NAb cross-reactivity to OxLDL and PC-BSA, as well as to binding by anti--T15-Id antibodies. Competition immunoassay studies indicated that the binding of natural serum IgM to OxLDL was inhibited by PC-BSA in a manner that was proportional to the relative use of the *DFL16.1* RF1 sequence ([Fig. 5 A](#fig5){ref-type="fig"}). In particular, PC-BSA completely failed to inhibit the binding of IgM from the pooled sera of *ΔD-iD* mice to OxLDL ([Fig. 5 A](#fig5){ref-type="fig"}). The T15-Id--specific antibody, AB1.2, was able to inhibit only a fraction of IgM binding to OxLDL in serum from *ΔD-DFL* and WT mice ([Fig. 5 B](#fig5){ref-type="fig"}). These findings were also replicated using OxLDL as a competitive inhibitor of binding to PC-BSA ([Fig. 5 C](#fig5){ref-type="fig"}). These data are in agreement with the observation that a major fraction of anti-PC antibodies, a significant proportion of which are T15-Id^+^, can be physiologically generated in the presence of germline-encoded *DFL16.1* sequence and cross-react with the endogenous antigen OxLDL ([@bib64]). However, our data go beyond these previous studies to strongly suggest that although anti-PC NAbs are still generated in the absence of germline *DFL16.1* sequence (e.g., in the *ΔD-iD* homozygous mice), these NAbs do not cross-react with the phospholipid-related epitope on OxLDL. Collectively, these results indicate that the elimination of germline *DFL16.1* sequence has severed the relationship between self-antigen--driven, antiatherogenic OxLDL NAb and anti-PC NAb production.

![**Loss of the canonical *DFL16.1* gene segment quantitatively severs NAb cross-reactivity between anti-PC and OxLDL.** (A and B) A constant amount of pooled sera from WT and D~H~-altered naive mice was incubated with OxLDL in the presence of increasing amounts of PC-BSA (A) and monoclonal AB1.2 anti--T15-Id antibody (B). Data are the mean of triplicate determinations expressed as ratio of IgM binding to OxLDL in the presence (B) or absence (B~0~) of competitor (B/B~0~). (C) A constant amount of pooled sera from WT and D~H~-altered naive mice was incubated with PC-BSA in the presence of increasing amounts of OxLDL. At least five sera samples were included in each pool. At least two independent experiments were performed.](JEM_20121861_Fig5){#fig5}

Immunization with heat-inactivated *S. pneumoniae* recovers the anti-PC but not the T15-Id^+^ response in mice lacking the *DFL16.1* gene segment
-------------------------------------------------------------------------------------------------------------------------------------------------

Although the levels and quality of the anti-PC NAb were significantly affected by the availability of *DFL16.1* gene segment sequence, the frequencies of PerC B-1a anti-PC clones were not. We thus tested the ability of the D~H~-altered mice to produce anti-PC antibodies after exogenous stimulation. The levels of anti-PC and the T15 components (T15-Id, *V~H~S107.1*, and *V~κ~22*) in the sera of each mouse strain were measured 7 d after immunization with heat-inactivated *S. pneumoniae*. Differing from the pattern observed in naive mice, anti-PC production in immunized homozygous *ΔD-iD* mice proved similar to that observed in WT and *ΔD-DFL* mice ([Fig. 6 A](#fig6){ref-type="fig"}). Thus, the link between *R* and anti-PC titers had also been severed ([Fig. 6 A](#fig6){ref-type="fig"}, inset).

![**Immunization with heat-inactivated *S. pneumoniae* recovers the anti-PC response but not the T15-Id^+^ in mice lacking the *DFL16.1* gene.** WT, as well as homozygous and heterozygous for each D~H~-altered mouse strain, mice were immunized i.v. with heat-inactivated *S. pneumoniae* (strain R36A), and serum was collected 7 d after immunization to measure the antibody levels. (A--D) Levels of serum IgM anti-PC (A), IgM expressing the T15-Id^+^ (B), IgM antibodies dependent on the use of the heavy chain *V~H~S107.1* gene segments, TC68^+^ (C), and IgM antibodies dependent on the use of the light chain *V~κ~22* gene segments, TC139^+^ (D), in WT and D~H~-altered mice 7 d after challenge with heat-inactivated *S. pneumoniae* (strain R36A). The levels of IgM antibodies for each mouse strain are plotted as a function of the relative use of *DFL16.1* in RF1 (*R* value). Levels of IgM antibodies are shown as an equivalent titer (µg/ml) to the BALB/c IgM anti-PC--producing hybridoma BH8 ([@bib41]). The data were combined from at least two independent experiments. The horizontal lines indicate the mean value of each group. Mean serum concentrations (±SD) of IgM anti-PC, T15-Id^+^, TC68^+^, or TC139^+^ from each mouse strain are presented as a function of *R* value. Significantly different from WT: \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001. Significantly different from *ΔD-DFL*: ^\#^, P ≤ 0.05; ^\#\#^, P ≤ 0.01; ^\#\#\#^, P ≤ 0.001.](JEM_20121861_Fig6){#fig6}

Importantly, the production of anti-PC antibodies was similar among six of the seven genotypes, but the production of T15-Id^+^ antibodies proved to be strongly influenced by the composition of the D~H~ locus ([Fig. 6 B](#fig6){ref-type="fig"}). A strong correlation between *R* and the T15-Id titer was observed (r = 0.82; P = 0.02; [Fig. 6 B](#fig6){ref-type="fig"}, inset). In particular, homozygous *ΔD-iD* mice demonstrated significant difficulty generating T15-Id^+^ antibodies (P \< 0.05 vs. WT and homozygous *ΔD-DFL*) even after antigen challenge. The levels of IgM antibodies using the V~H~S107.1 were similar among homozygous *ΔD-iD*, WT, and *ΔD-DFL* mice after immunization ([Fig. 6 C](#fig6){ref-type="fig"}), and the correlation between *R* and the use of *V~H~S107.1* was extremely weak at best (r = 0.75; P = 0.068; [Fig. 6 C](#fig6){ref-type="fig"}, inset). However, as was the case in naive mice, the prevalence of serum antibodies containing the *V~κ~22* light chain in the seven genotypes was comparable with that observed in antibodies with anti-PC reactivity ([Fig. 2, A and D](#fig2){ref-type="fig"}; and [Fig. 6, A and D](#fig6){ref-type="fig"}). The production of *V~κ~22*-bearing antibodies was significantly higher than WT in both *ΔD-iD* (P \< 0.001) and *ΔD-DFL* homozygous mice (P \< 0.001) and significantly lower in heterozygous *ΔD-iD* mice (P \< 0.001). Caused in part by the markedly higher titer of IgM antibodies containing *V~κ~22* light chain in homozygous *ΔD-iD* mice, there was no correlation between *R* and *V~κ~22* usage (r = 0.23; P = 0.62; [Fig. 6 D](#fig6){ref-type="fig"}, inset). These data show that immunization promotes a serum anti-PC response even when germline-encoded *DFL16.1* gene sequence is not available, further confirming that the potential to secrete anti-PC antibodies is intact in all D~H~-altered mouse strains, as was also observed after polyclonal stimulation in the LDA ([Fig. 2 D](#fig2){ref-type="fig"}).

Availability of evolutionarily conserved *DFL16.1* RF1 amino acid sequence is a critical factor for survival against challenge with live *S. pneumoniae*
--------------------------------------------------------------------------------------------------------------------------------------------------------

The serum level of anti-PC antibodies in *ΔD-iD* mice after immunization with heat-inactivated bacteria proved indistinguishable from WT ([Fig. 6 A](#fig6){ref-type="fig"}), raising the question of whether the anti-PC antibody repertoire created in the complete absence of *DFL16.1* RF1 sequence (see [Fig. 5 B](#fig5){ref-type="fig"}), but with full access to *V~H~S107.1*, *J~H~1*, *V~κ~22*, and *J~κ~5*, would be able to protect against experimental infection with live *S pneumoniae*. We thus challenged cohorts of homo- and heterozygous *ΔD-iD* and WT mice with live *S. pneumoniae*. 7 d after challenge, survival of the WT (15 of 21) and heterozygous *ΔD-iD* mice (15 of 21) was significantly greater than that of the homozygous *ΔD-iD* mice (5 of 21; P \< 0.001; [Fig. 7 A](#fig7){ref-type="fig"}). To assess whether the *ΔD-iD* mice that survived challenge with live *S. pneumoniae* had managed to produce levels of anti-PC and the protective T15 antibodies equivalent to WT or heterozygous control, the serum concentration of PC-binding antibodies and the titers of antibodies in the sera that expressed the T15-Id, *V~H~S107.1*, or *V~κ~22* markers were then measured in blood samples obtained from the survivor mice ([Fig. 7 B](#fig7){ref-type="fig"}).

![**The availability of the *DFL16.1* sequence is critical for survival after challenge with live *S. pneumoniae.*** (A) WT, homozygous, and heterozygous *ΔD-iD* mice were inoculated i.v. with live *S. pneumoniae* (strain A66.1), and survival was monitored. Serum was collected from the survivors 7 d after infection to measure the antibody levels. (B--E) Levels of serum IgM anti-PC (B), IgM expressing the T15-Id^+^ (C), IgM antibodies dependent on the use of the heavy chain *V~H~S107.1* gene segments, TC68^+^ (D), and IgM antibodies dependent on the use of the light chain *V~κ~22* gene segments, TC139^+^ (E), in WT, heterozygous, and homozygous *ΔD-iD* mice that survived after challenge with live *S. pneumoniae* (strain A66.1). The levels of IgM antibodies for each mouse strain are plotted as a function of the relative use of *DFL16.1* in RF1 (*R* value). The horizontal lines indicate the mean value of each group. (inset plots) Mean serum concentrations (±SD) of IgM anti-PC, T15-Id^+^, TC68^+^, or TC139^+^ from each mouse strain are presented as a function of *R* value. Levels of IgM antibodies are shown as an equivalent titer (µg/ml) to the BALB/c IgM anti-PC--producing hybridoma BH8 ([@bib41]). The data were combined from three independent experiments.](JEM_20121861_Fig7){#fig7}

Although the majority of *ΔD-iD* mice died from the infection, anti-PC production in the surviving homozygous *ΔD-iD* mice matched that observed in surviving WT or heterozygous *ΔD-iD* mice. However, the variance was pronounced within the homozygous *ΔD-iD* serum samples ([Fig. 7 B](#fig7){ref-type="fig"}), and a correlation between *R* and anti-PC serum levels was not observed (r = 0.95; P = 0.20; [Fig. 7 B](#fig7){ref-type="fig"}, inset). Serum levels of antibodies bearing the T15-Id in the surviving homozygous *ΔD-iD* mice remained at baseline and were significantly decreased when compared with WT or heterozygous *ΔD-iD* littermate survivors (P \< 0.001; [Fig. 7 C](#fig7){ref-type="fig"}). The correlation between *R* value and T15 serum concentration did not achieve statistical significance (r = 0.99; P = 0.06; [Fig. 7 C](#fig7){ref-type="fig"}, inset). The prevalence of antibodies using *V~H~S107.1* was the same among all the survivors irrespective of genotype ([Fig. 7 D](#fig7){ref-type="fig"}), and no significant correlation between *R* and *V~H~S107.1* prevalence (r = 0.83; P = 0.38; [Fig. 7 D](#fig7){ref-type="fig"}, inset) was observed. The prevalence of antibodies using *V~κ~22* was again the same among all the survivors irrespective of genotype ([Fig. 7 E](#fig7){ref-type="fig"}), and again no correlation between R and *V~κ~22* prevalence (r = 0.98; P = 0.13; [Fig. 7 E](#fig7){ref-type="fig"}, inset) was observed.

DISCUSSION
==========

Using genetically manipulated mice, we have previously shown the importance of conserved D~H~ gene sequence content in delimiting the composition of the CDR-H3 repertoire ([@bib63]). However, constraints in the CDR-H3 repertoire were also observed in unmanipulated WT mice ([@bib36]; [@bib61]; [@bib72]), suggesting a role for naturally selected D~H~ genes in defining the composition of the NAb repertoire and, by doing so, potentially regulating NAb functions. The key roles played by NAbs in host defense have been extensively documented ([@bib9]; [@bib5]; [@bib55]; [@bib77]; [@bib58]), and more recently their roles in tissue homeostasis have become increasingly appreciated ([@bib64]; [@bib7]; [@bib11]; [@bib43]; [@bib39]). Nevertheless, major questions regarding the forces that shape the NAb repertoire remain unanswered. In this study we tested two, in many ways competing, hypotheses: first, that the germline composition of the NAb repertoire is critical for its dual function as a protector against both endogenous and exogenous antigens and, second, that exposure to self-antigen drives the production of these functional NAbs irrespective of germline sequence. Although these hypotheses are not mutually exclusive, they imply major differences regarding the forces that underlie the generation of the NAb repertoire, and the predominance of one upon the other would have distinct functional consequences.

We found that serum IgM NAb from D~H~-altered mice have reactivity patterns that are predominantly focused on the same self-antigens that dominate the NAb repertoire in WT animals (Fig. S1 A). These data not only reinforce the view that self-antigens drive the production of NAb reactivities, as previously shown by [@bib32], but also suggest that this property of NAb elicitation is preferentially driven by a delimited subset of the self-antigens ([@bib51]).

It is well established that antigen-binding specificity does not always correlate with antibody function ([@bib3]); therefore, the study of the well-defined T15 system as an exemplar of the role of NAbs in protection against both endogenous and exogenous deleterious antigens was instrumental to test our competing hypothesis. In the absence of evolutionary conserved D~H~ sequence, we find that somatic selection continues to elicit a set of NAbs capable of preventing the uptake of OxLDL by macrophages ([Fig. 1](#fig1){ref-type="fig"}). To the extent that this activity reflects the ability of these NAbs to function in normal cellular homeostasis, these data support the view that production of these NAbs is driven by self-antigen and somatic selection. Furthermore, the data suggest that access to conserved germline D~H~ sequence is not required to generate a fully functional physiological repertoire against self-antigens of this type.

In the case of the exogenous antigen, however, the answer proved quite different. Normal mice challenged with *S. pneumonia* produce high levels of protective anti-PC T15-Id^+^ antibodies, mainly derived from B-1a cells ([@bib9]; [@bib41]). The PC epitopes recognized by T15-Id^+^ antibodies are found both on OxLDL as well on the bacteria cell wall. Accordingly, it has been suggested that the T15 clonotype has been conserved during evolution because of its value both for protection against host damage by oxidatively modified self-structures and for defense against infection with PC-bearing pathogens ([@bib69]). However, the severing of the relationship between the production of NAbs against OxLDL and NAbs against PC in our D~H~-altered mice indicates that the concordance between these activities requires access to conserved germline D~H~ sequence content.

A recent study showed that deletion of the conserved *V~H~S107.1* gene, which is dominant among anti-PC antibodies, led to changes in epitope recognition on apoptotic cells ([@bib11]). In light of our data, we suggest that the NAb repertoire produced in the absence of *DFL16.1* sequence no longer recognizes PC as the major phospholipid-related epitope on OxLDL, being hierarchically replaced, possibly by an alternative epitope such as malondialdehyde ([@bib11]). We propose that a large assortment of redundant anti-self NAbs reactive with alternative epitopes are available and able to play a role in tissue homeostasis, irrespective of the presence of evolutionary conserved gene segments. This suggests that major NAb clones, T15 in particular, have been fixed and predominant across evolution through natural selection for both homeostasis and host defense against common pathogens.

The serum concentration and quality of anti-PC antibodies in naive mice proved dependent on the availability of *DFL16.1* sequence. The analysis of the actual composition of the PC-specific heavy chain repertoire in B-1a cells from the D~H~-altered mice revealed that, when there is forced reduction of availability to *DFL16.1* RF1 sequence, a compensatory increase in the frequencies of alternative V~H~ and J~H~ genes occurs that otherwise would be biased toward *V~H~S107.1*/*J~H~1* gene usage ([@bib17]). In mice forced to preferentially use charged CDR-H3s (*ΔD-iD*), we observed extensive exonucleolytic nibbling among the B-1a anti-PC transcripts to the extent that 30% of the anti-PC CDR-H3 sequences did not contain an identifiable *iD* sequence. We also observed a higher frequency of N-region additions compared with the non--anti-PC transcripts from B-1a cells (unpublished data). These findings reveal the existence of robust somatic selection operative on D~H~-altered B cells and support the concept that the unusual CDR-H3 imposed by the *iD* transgene might inhibit the physiological humoral immune response to PC. Strikingly, we observed an increase in clonal diversity within the anti-PC B-1a cells as the *DFL16.1* gene segment became less available for use. Our findings therefore show that limiting the availability of an evolutionary conserved D~H~ element encoding a major B cell clonotype generates a whole new set of diversified B cell clones to fill the gap left by the missing clone. Thus, contrasting with the original nomenclature, the limitation/alteration of the D~H~ gene, defined as "D" for "diversity" ([@bib15]), which a priori would reduce the diversity of B cell precursors, led surprisingly to a more polyclonal and diversified response than the otherwise oligoclonal anti-PC immune response observed in WT animals ([@bib16]; [@bib65]; [@bib25]; [@bib17]).

Several mechanisms have been proposed to explain the T15 immunodominance in BALB/c mice, which is established early in ontogeny ([@bib14]; [@bib21], [@bib22]). This includes microhomology between the ends of the V~H~ and J~H~ gene segments and the ends of the D~H~ gene segments that, in the absence of N addition, drives rearrangement site preferences ([@bib21]). As a result, the prototypic T15 V-D and D-J junctions are the most common junctional sequences among *V~H~S107.1*-*D~H~DFL16.1*-*J~H~1* genes in neonatal B cells ([@bib21]). Likely because of both the high affinity of the T15 antibodies ([@bib23]) and to the self-replenishing nature of the B-1a cells that produce them ([@bib31]; [@bib74]; [@bib46]; [@bib37]), it has been suggested that these characteristics would be sufficient to establish the T15 dominance for life ([@bib42]). As previously suggested, these limitations in the neonatal repertoire may have evolved to reproducibly provide certain specificities that are essentials for the survival of the species, supporting the idea of a layered immune system ([@bib33]).

However, our findings reported here reopen this discussion and raise alternative interpretations. The *ΔD-DµFS* allele contains a single *DFL16.1* gene segment that has been doubly frameshifted to enable microhomology-driven rearrangement to preferentially access valine-enriched RF2 sequence in place of tyrosine-enriched RF1. Although access to the RF1 core is still possible, albeit at one-third the frequency, a termination codon was introduced into the third codon from the 3′ end of this RF, thereby destroying a part of the sequence used for the canonical T15 CDR-H. Thus, the rearrangement limitations of the neonatal B cell repertoire that normally ensure the conservation of the T15 clonotype have been subverted in *ΔD-DµFS* mice and require significant somatic modification to be allowed to contribute to the formation of classical T15 CDR-H3 amino acid sequence. Our finding of the T15 heavy chain prototype sequence among the *ΔD-DµFS* transcripts thus means that at least three of the mechanisms that normally limit the neonatal repertoire were subverted: (1) the aforementioned role of microhomology between V-D and D-J junctions, which would otherwise generate the hydrophobic-enriched RF2; (2) extensive exonucleolytic nibbling to eliminate the termination codon; and (3) addition of N nucleotides in the germline-enriched B-1a compartment to recreate the full DFL16.1 RF1 amino acid sequence. Indeed, we found additions of a "C" nucleotide at the V-D junction and "TC" nucleotides at the D-J junction, which completely abrogate the microhomology sites at both ends of the D~H~, concomitantly recreating the T15 amino acid sequence. These observations suggest that there may be a sufficient imperative to create certain clonotypes within the NAb repertoire such that somatic selection can overcome germline limitations to recapitulate the lost "normal" repertoire. More importantly, these mechanisms of endogenous antigen-driven selection proved to be at work during immune homeostasis and powerful enough to be effective without any intentional immunization in the *ΔD-DμFS* mouse. However, this somatic drive clearly has limits because the *ΔD-iD* mouse, which completely lacks *DFL16.1* RF1 sequence, was unable to recreate this sequence, at least at the limits of our ability to detect it by flow cytometry and sequencing.

Unlike in the *V~H~S107.1* deficiency model ([@bib48]), all immunized D~H~-altered mice mounted a similar anti-PC response compared with the WT. More importantly, the anti-PC levels were indistinguishable between homozygous *ΔD-iD* and *ΔD-DFL* mice after immunization, even though the T15 response was not recovered in mice lacking the *DFL16.1* RF1 sequence altogether. Thus, the availability of *DFL16.1* core sequence proved to be necessary only to create a robust T15 response. The serum level of TC139^+^ antibodies, reflecting the use of the *V~κ~22* light chain, was slightly increased in *ΔD-iD* mice compared with the other mouse strains, suggesting a compensatory expansion of clones using the prototypic T15 light chain combined with heavy chains other than the canonical T15 *V~H~S107.1*. The *ΔD-DµFS* mice, which can encode the V~H~-T15 at the amino acid level, had serum levels of both anti-PC and T15-Id^+^ antibodies comparable with WT after immunization. However, the variance in the T15-Id^+^ antibody levels observed among the different *ΔD-DµFS* samples provides evidence for the difficulty in recapitulating the T15 clonotype in this mouse strain, possibly reflecting the low frequency of anti-PC T15-Id^+^ B-1a cells, as illustrated in [Fig. 3 (E and F)](#fig3){ref-type="fig"} and at the sequence level in [Fig. 4 C](#fig4){ref-type="fig"}.

Our earlier experiments pointed out the importance of the NAb CDR-H3 in its germline configuration to provide immune protection against *S. pneumoniae* ([@bib5]). Here we also tested the effects of the absence of *DFL16.1* gene segment on survival after challenge with live *S. pneumoniae.* The infected mice were able to produce abundant anti-PC antibodies, and both *V~H~S107.1* and *V~κ~22* sequences were used. Although, our analysis limits conclusions about the antibody response of the initial cohort of mice, we found that 7 d after challenge with live bacteria, only the homozygous *ΔD-iD* mice were unable to produce T15-Id^+^ antibodies. However, the anti-PC antibodies produced by these mice were less protective with significantly higher mortality observed in homozygous *ΔD-iD* compared with both heterozygous *ΔD-iD* and WT mice. Thus, naturally selected DFL16.1 germline sequence content is essential for the production of T15-Id^+^ antibodies and is vital for mounting a successful defense against *S. pneumonia*.

Our findings provide the first evidence, to our knowledge, that the composition of the germline D~H~ locus, in concert with endogenous antigen-driven selection, can both qualitatively and quantitatively regulate the antigen-binding site features of the NAb repertoire and, by so doing, can control the ability of the host to protect against bacterial infection. However, the structural and chemical composition of the NAb paratope repertoire clearly differs, as demonstrated by our sequence analysis. One consequence of this divergence is the severing of the relationship between self-antigen recognition and protection against common pathogens, as illustrated by the T15 anti-PC response.

Collectively, these data may have important implications for the rational design of vaccines against hard-to-defend pathogens such as HIV. The first scenario, in which the protective B cell clones are not available, may help explain why classical vaccine intervention may not be able to easily create a protective immune response without requiring extensive somatic hypermutation ([@bib50]; [@bib59]). Instead, classical vaccine protocols may be more likely to induce a polyclonal expansion of vaccine-specific B cells able to produce a diverse, albeit nonprotective and perhaps deleterious, antibody response ([@bib53]; [@bib45]; [@bib57]). In a second scenario in which the potentially protective B cell clones are available but at low frequencies or in nonchallenged B cell compartments, it is possible that vaccine protocols could be modified to elicit the desired responses at the levels needed to provide protection against future infections. In general, immunogen design will need to address the germline sequence--dependent likelihood of encountering or promoting high-affinity antibodies bearing antigen-binding sites that properly engage critical epitopes on the microorganism. Our D~H~-altered mouse model provides one approach to testing these hypotheses and thus working out how essential aspects of B cell development and selection of the natural available repertoire influence vaccine responses and thus contribute to the likely success of rational vaccine strategies.

MATERIALS AND METHODS
=====================

### Mice.

The panel of D~H~-altered *ΔD-DFL* ([@bib60]), *ΔD-DμFS* ([@bib62]; [@bib76]), or *ΔD-iD* ([@bib35]) backcrossed to BALB/c for 22 generations and WT BALB/c littermates were bred in our mouse colony at the University of Alabama at Birmingham (UAB). Animal care was conducted in accordance with established guidelines and protocols approved by the UAB Animal Care and Use Committee. Each mouse strain carries its unique D~H~-altered allele as follows. The *ΔD-DFL* allele provides access to only the germline *DFL16.1* gene segment, increasing its contribution from 20% of the developing repertoire to 100%. The *ΔD-DµFS* allele contains a single *DFL16.1* gene segment that has been doubly frameshifted to promote the use of valine-enriched RF2. Access to the RF1 sequence remains but at one-third the frequency and with the frameshift insertion of a termination codon at the third position from the 3′ terminus. In the *ΔD-iD* allele, the sequence of inverted *DSP2.2* has been embedded within *DFL16.1*. The *ΔD-iD* allele lacks the *DFL16.1* sequence altogether. Together, this panel of D~H~-altered mice presents varying levels of availability of germline DFL16.1 sequence (0--100%).

### The *R* value: relative use of *DFL16.1* in RF1.

In WT BALB/c mice, the major T15 prototype uses germline *DFL16.1* RF1 sequence without N-region addition ([@bib21]). To perform quantitative calculations relating the likelihood of the use of *DFL16.1* RF1 sequence to the prevalence of antibodies bearing the T15-Id, we developed a parameter we term *R* value ([Table 1](#tbl1){ref-type="table"}), which reports the expected frequency of mature B cells using the *DFL16.1* in RF1 in our D~H~-altered mice relative to WT. The calculation of *R* value takes into account the observed proportion of mature, recirculating IgM^+^ IgD^+^ B cells in the bone marrow relative to WT (R1), the expected frequency of use of the *DFL16.1* gene segment relative to WT (R2), and the frequency of use of *DFL16.1* in RF1 (R3), whether the mouse strain in question is homozygous or heterozygous for the mutant D~H~ allele. The *R* values for each genotype are represented in the [Table 1](#tbl1){ref-type="table"} and were calculated based on previous published data (for *ΔD-DµFS* mice see [@bib62] and [@bib76], and for *ΔD-iD* mice see [@bib35]), according to the following formula:$$R\,\text{value}\, = \,\frac{R_{\text{alle}\,\text{A}}\left( {\text{R}1 \times \text{R}2 \times \text{R}3} \right) + R_{\text{alle}\,\text{B}}\left( {\text{R}1 \times \text{R}2 \times \text{R}3} \right)}{2}.$$

### Serum assays of antibodies.

The en bloc analysis of serum IgM reactivities was performed using a semiquantitative immunoblot assay. The method has been previously described ([@bib54]; [@bib27], [@bib28]). Specific antibody titers to OxLDL were determined by ELISA as previously described ([@bib52]; [@bib70]), using native LDL (Nat-LDL) and OxLDL (MyBioSource). Quantitative ELISA assays to determine the serum levels of anti-PC and T15-Id^+^ antibodies were performed as previously described ([@bib41]; [@bib19]). The following reagents were used: PC-BSA (high loaded PC-BSA), the monoclonal AB1.2 anti-idiotypic antibody against T15 ([@bib41]), the monoclonal antibody TC68 against *V~H~S107.1*, and the monoclonal antibody TC139 against *V~κ~22* ([@bib19]). The levels of IgM antibodies in each mouse strain are shown as an equivalent titer to the BALB/c IgM anti-PC--producing hybridoma BH8 ([@bib41]). The standard curve was used to calculate the equivalent titer of antibodies in each sample.

### Macrophage binding/uptake assays.

Binding/uptake of OxLDL to macrophages was assessed by three different approaches, immunoenzymatic, flow cytometry analysis, and confocal microscopy, based on several previous studies ([@bib34]; [@bib7]; [@bib49]; [@bib75]). A murine macrophage cell line, RAW 264.7 (American Type Culture Collection), was used for all assays described, and the cells were cultured according to [@bib75]. Immunoenzymatic assay was performed to assess the inhibition of binding of biotinylated-OxLDL (Biot-OxLDL) to 10^5^ RAW macrophages plated in microtiter wells. To detect the 2 µg/ml Biot-OxLDL bound to RAW macrophages, we used streptavidin coupled with alkaline phosphatase, and the binding is expressed as OxLDL bound to macrophages in optical density at 405 nm. A flow cytometric approach was used to determine the inhibition of binding of 5 µg/ml Biot-OxLDL to 5 × 10^5^ RAW macrophages. The intensity of fluorescence (streptavidin-PE) was indicative of Biot-OxLDL binding to macrophages. The inhibition of binding is depicted in the histogram graphs expressing the intensity of fluorescence, and the statistical analyses were performed using the mean fluorescence intensity of each sample, according to [@bib75]. Confocal microscopy was used to determine the inhibition of binding/uptake of DiI-OxLDL by RAW macrophages. For nucleus staining, the cells were incubated for 10 min with 10 µg/ml DAPI (Sigma-Aldrich) and washed. The cells were then placed for confocal microscopy (LSM710; Carl Zeiss). For all three approaches, the binding/uptake of OxLDL to RAW macrophages was determined in the absence or presence of diluted pooled sera from each mouse strain. The specificity of the binding/uptake of OxLDL (either Biot- or DiI-OxLDL) was determined in the absence and presence of 50-fold unconjugated OxLDL or Nat-LDL as competitors.

### Competition immunoassay.

The specificity of IgM antibodies binding to PC and/or OxLDL was determined by competition immunoassays as described previously ([@bib7]; [@bib13]). In brief, sera from each mouse strain was pooled, diluted to 1:100, and incubated overnight at 4°C in the presence or absence of increasing concentrations of competitors. Samples were then centrifuged at 15,800 *g* for 45 min at 4°C, and supernatants were analyzed for binding to the respective antigen by ELISA.

### Flow cytometry and cell sorting.

Single-cell suspensions prepared from PerC and spleen were stained with the following fluorochrome-conjugated antibodies purchased from BD or eBioscience: anti-B220 PB (RA 3.6B2), anti-CD5 PE (53-7.3), anti--Mac-1 FITC (M1/70), and anti-CD138 PE (281-2). For anti-PC analysis, we used PC-DEX FITC (provided by J. Kenny, National Institute on Aging, National Institutes of Health, Baltimore, MD) and anti--T15-Id AB1.2 APC ([@bib41]). Analysis and sorting were then performed on an LSR II (BD) and MoFlo instrument (Dako), respectively. For B cell cultures, the cells were collected directly in sterile tubes containing RPMI medium and for mRNA purification the cells were collected directly in RLT lysis buffer (RNeasy mini-kit; QIAGEN).

### B cell culture and LDA.

Cultures of sorted B cell, stimulated with LPS, were performed as described previously ([@bib73]). Sorted B cells were cultured at variable numbers in 24 replicates for each cell concentration, as follows: 18, 6, 2, and 0.66 B cells per well, to determine the frequency of IgM-secreting clones by ELISA according to Poisson's distribution and 10,000, 3,333, 1,111, 370, 123, 41, and 14 B cells per well to estimate the clonal frequencies of antigen-specific (PC) and/or idiotype-positive B cells (T15-Id^+^) using ELISA. Culture supernatants were harvested usually on the ninth day of culture and analyzed by ELISA.

### RT-PCR, cloning and sequencing.

For each mouse strain, B-1a cells PC-DEX^+^/AB1.2^+^ diagonal high and low (see [Fig. 4 A](#fig4){ref-type="fig"}) were sorted directly into RLT lysis buffer. Cells were sorted from at least five mice per group and then pooled to achieve sufficient numbers of cells to allow for RNA extraction and sequencing. RNA isolation, RT-PCR amplification, and sequencing analysis were performed as previously described ([@bib36]), except for the V~H~ primer. To screen for anti-PC Cµ transcripts without missing the true dimension of the repertoire, we intentionally used a V~H~ primer that biases toward the *V~H~S107* family but also allows the amplification of other V~H~ family members ([@bib20]). In the present work, we used S107-1 primer 5′-GGTGAAGCTTGTGGAATCTGGAGGA-3′, as previously described by [@bib20]. We used One-step RT-PCR kits (QIAGEN) for amplification. RT-PCR conditions were 50°C for 30 min, 95°C for 15 min, and then 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min for 35 cycles, and then 72°C for 10 min. PCR products were cloned into TOPO-TA vector and transformed into TOP10 competent bacteria (Invitrogen). QIAprep Miniprep kits (QIAGEN) were used to isolate plasmid DNA from colonies. Plasmid DNAs were sequenced at the DNA Sequencing and Analysis Core at the UAB.

### Immunization with heat-inactivated *S. pneumoniae*.

A heat-inactivated preparation of strain R36A of *S. pneumoniae* was used. 8--12 wk-old WT, as well as *ΔD-DFL*/*ΔD-DFL*, *ΔD-DFL*/WT, *ΔD-DμFS*/*ΔD-DμFS*, *ΔD-DμFS*/WT, *ΔD-iD*/*ΔD-iD*, and *ΔD-iD*/WT mice, were immunized i.v. with 10^8^ heat-inactivated/100 µl, pepsin-treated *S. pneumoniae* (strain R36A) as previously described ([@bib10]). The number of mice in each group is given with the results. Blood was collected retroorbitally before and 7 d after infection. Mice were euthanized 7 d after immunization.

### Infection with live *S. pneumoniae*.

Live *S. pneumoniae* strain A66.1 was prepared according to [@bib9]. 8--12 wk-old WT, homozygous *ΔD-iD*, and heterozygous *ΔD-iD*/WT mice were inoculated in the tail vein with 9,120--9,750 CFU/200 µl *S. pneumoniae* (strain A66.1). Blood was collected retroorbitally before and 7 d after infection. Mice were closely monitored for mortality until all surviving mice showed no signs of morbidity (hunched back, poor grooming, irritability, or unresponsiveness to touch), which occurred at 7 d after infection. Surviving mice were monitored daily for 21 d, at which time they were euthanized by CO~2~ narcosis, followed by cervical dislocation.

### Statistical analysis.

Data were analyzed using SigmaPlot version 11 (SYSTAT Software, Inc). One-way ANOVA was performed if data in multiple groups were normally distributed with equal variance. The Kruskal-Wallis one-way ANOVA on ranks was used if three or more groups were compared and the data were not normally distributed with equal variance. If these tests indicated that the groups were significantly different, we used an All Pairwise Multiple Comparison Procedure, Holm-Sidak, or Dunn method, respectively, to determine which of the groups were significantly different from the others. Pearson's correlation coefficient r was calculated to evaluate relations. The Gehan-Breslow test was used to analyze survival after infection with live bacteria. Rejecting the null hypothesis at α = 0.05 with a p-value \< 0.05 was interpreted to indicate a significant difference.

### Online supplemental material.

Fig. S1 shows the immunoblot patterns of reactivity against self-antigens (brain extract) using IgM from sera and supernatants of B cell cultures from WT, *ΔD-DFL*, and *ΔD-iD* mice. Table S1, included as a separate Excel file, provides the CDR-H3 nucleotide sequences from VDJCµ transcripts cloned from PC-DEX^lo^/AB1.2^lo^ and PC-DEX^hi^/AB1.2^hi^ B-1a cells from each of the mouse strains; each of these CDR-H3 sequences is compared with the T15 prototype. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20121861/DC1>.
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